Ignite Creation Date:
2025-12-25 @ 3:09 AM
Ignite Modification Date:
2026-02-25 @ 11:01 PM
Study NCT ID:
NCT02853305
Status:
COMPLETED
Last Update Posted:
2023-09-08
First Post:
2016-07-29
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Pembrolizumab With or Without Platinum-based Combination Chemotherapy Versus Chemotherapy Alone in Urothelial Carcinoma (MK-3475-361/KEYNOTE-361)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-09-15
Start Date Type:
ACTUAL
Primary Completion Date:
2020-04-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-09-15
Completion Date Type:
ACTUAL
First Submit Date:
2016-07-29
First Submit QC Date:
None
Study First Post Date:
2016-08-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-04-28
Results First Submit QC Date:
None
Results First Post Date:
2021-05-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-14
Last Update Post Date:
2023-09-08
Last Update Post Date Type:
ACTUAL